Axsome Therapeutics, Inc.

8-K Other events Jul 15, 2026 8-K Director or officer change Jun 9, 2026 8-K Shareholder vote results Jun 9, 2026 8-K Other events Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release); Other events May 4, 2026 8-K Other events Apr 30, 2026 8-K Other events Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Feb 23, 2026 8-K Results of operations (earnings release) Feb 23, 2026 8-K Other events Feb 17, 2026 8-K Results of operations (earnings release); Other events Jan 12, 2026 8-K Other events Dec 31, 2025 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release); Other events Nov 3, 2025 8-K Other events Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release); Other events Aug 4, 2025 8-K Other events Jun 10, 2025 8-K Shareholder vote results Jun 9, 2025 8-K Other events Jun 9, 2025 8-K Other events May 27, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events May 13, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release); Other events May 5, 2025 8-K Other events Apr 1, 2025 8-K Other events Mar 25, 2025 8-K Other events Mar 5, 2025 8-K Other events Mar 3, 2025 10-K Fiscal year ended 2024-12-31 Feb 18, 2025 8-K Results of operations (earnings release); Other events Feb 18, 2025 8-K Other events Feb 10, 2025 8-K Other events Jan 31, 2025 8-K Results of operations (earnings release); Other events Jan 13, 2025 8-K Other events Dec 30, 2024 8-K Other events Nov 26, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Other events Nov 12, 2024 8-K Entered a material agreement Oct 1, 2024 8-K Other events Sep 4, 2024